
Gilead Sciences, Inc.: updates and filings
Price
$168.98
November 18, 2026Market cap $210B
What Ploutos Investor adds for Gilead Sciences
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Oct 29, 2026next Feb 1, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
October 2026
August 2026
May 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 6, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Nov 6, 2026Its own holdings as an investment manager (13F)Form13F-HR
- Oct 30, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Oct 29, 2026Results of operationsForm8-K
- Aug 26, 2026FilingFormN-PX
- Aug 7, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Aug 6, 2026Shelf registration for future offeringsFormS-3ASR
- Aug 6, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 4, 2026Results of operationsForm8-K
- Aug 3, 2026Its own holdings as an investment manager (13F)Form13F-HR
- May 27, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- May 20, 2026Material agreement entered, new material financial obligation, other material eventsForm8-K
- May 8, 2026Its own holdings as an investment manager (13F)Form13F-HR
- May 7, 2026Shares registered for employeesFormS-8
- May 7, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 7, 2026Results of operationsForm8-K
- May 4, 2026Shareholder voteForm8-K
- Apr 29, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Apr 28, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Apr 28, 2026Regulation FD disclosure, other material eventsForm8-K
- Apr 28, 2026Filing (amendment)FormSC TO-T/A
- Apr 17, 2026Filing (amendment)FormSC TO-T/A
- Apr 1, 2026Filing (amendment)FormSC TO-T/A
- Mar 26, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Mar 20, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 6, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Nov 6, 2026 | 13F-HR | Its own holdings as an investment manager (13F) | Document |
| Oct 30, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Oct 29, 2026 | 8-K | Results of operations | Document |
| Aug 26, 2026 | N-PX | Filing | Document |
| Aug 7, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Aug 6, 2026 | S-3ASR | Shelf registration for future offerings | Document |
| Aug 6, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 4, 2026 | 8-K | Results of operations | Document |
| Aug 3, 2026 | 13F-HR | Its own holdings as an investment manager (13F) | Document |
| May 27, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| May 20, 2026 | 8-K | Material agreement entered, new material financial obligation, other material events | Document |
| May 8, 2026 | 13F-HR | Its own holdings as an investment manager (13F) | Document |
| May 7, 2026 | S-8 | Shares registered for employees | Document |
| May 7, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 7, 2026 | 8-K | Results of operations | Document |
| May 4, 2026 | 8-K | Shareholder vote | Document |
| Apr 29, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Apr 28, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Apr 28, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| Apr 28, 2026 | SC TO-T/A | Filing (amendment) | Document |
| Apr 17, 2026 | SC TO-T/A | Filing (amendment) | Document |
| Apr 1, 2026 | SC TO-T/A | Filing (amendment) | Document |
| Mar 26, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Mar 20, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC since Feb 14, 1994: every report, 8-K, meeting and letter. Of its other filings (1,030 in all), the newest. Of its note and share prospectuses (424B, FWP), the newest 40 of 57.
The full analysis
What do Gilead Sciences's filings show?
The filings are where every one of Gilead Sciences's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.